Humboldt Fund is a venture capital firm backing U.S. startups from seed through later-stage venture rounds, with a focus on biotechnology and life sciences alongside related pharmaceuticals, foodtech and biomaterials opportunities. The firm has co-led Series A financings and invests across areas such as gene editing, stem-cell automation, therapeutics, synthetic biology and materials.